Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study
2004; Springer Nature; Volume: 18; Issue: 5 Linguagem: Inglês
10.1038/sj.leu.2403336
ISSN1476-5551
AutoresJerzy Hołowiecki, Sebastian Grosicki, Tadeusz Robak, Sławomira Kyrcz‐Krzemień, Sebastian Giebel, Andrzej Hellmann, A B Skotnicki, W Wiktor-Jędrzejczak, L Konopka, Kazimierz Kuliczkowski, Barbara Zdziarska, Anna Dmoszyńska, B Mariańska, Agnieszka Pluta, Krystyna Zawilska, Mieczysław Komarnicki, Janusz Kłoczko, K Sułek, Olga Haus, Beata Stella‐Hołowiecka, Wojciech Baran, Beata Jakubas, Monika Paluszewska, Agnieszka Wierzbowska, Marek Kiełbiński, Krystyna Jagoda,
Tópico(s)Acute Lymphoblastic Leukemia research
Referência(s)